10x Genomics, Inc. (LON:0A88)
London · Delayed Price · Currency is GBP · Price in USD 20.01
-0.37 (-1.82%)
At close: Feb 2, 2026
10x Genomics Market Cap
10x Genomics has a market cap or net worth of 1.78 billion as of February 4, 2026. Its market cap has increased by 18.98% in one year.
Market Cap
1.78B
Enterprise Value
1.49B
Revenue
477.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
20.01
Market Cap Chart
Since September 12, 2019, 10x Genomics's market cap has decreased from 4.01B to 1.78B, a decrease of -55.61%. That is a compound annual growth rate of -11.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 1.78B | 16.17% |
| Dec 31, 2025 | 1.53B | 10.45% |
| Dec 31, 2024 | 1.39B | -73.26% |
| Dec 29, 2023 | 5.19B | 50.02% |
| Dec 30, 2022 | 3.46B | -71.83% |
| Dec 31, 2021 | 12.29B | 10.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caledonia Investments | 1.94B |
| TP ICAP Group | 1.90B |
| Goodwin | 1.88B |
| Hammerson | 1.88B |
| Dunelm Group | 1.86B |
| AJ Bell | 1.85B |
| Ocado Group | 1.81B |
| Safestore Holdings | 1.81B |